LG Life Sciences
lgchem.comTotal trials
78
Active
0
Phase 3
23
Total enrollment
20,755
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Healthy16
- Type 2 Diabetes Mellitus7
- Chronic Hepatitis B3
- ST-segment Elevation Myocardial Infarction2
- Hyperlipidemia2
- Type 2 Diabetes2
- Infectious Disease by Haemophilus Influenzae Type b2
- Correction of Nasolabial Folds2
Frequently asked questions about LG Life Sciences
- How many clinical trials does LG Life Sciences have on ClinicalTrials.gov?
- LG Life Sciences is listed as the lead sponsor on 78 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of LG Life Sciences's trials are in Phase 3?
- 23 of LG Life Sciences's trials are in Phase 3.
- What therapeutic areas does LG Life Sciences focus on?
- LG Life Sciences's most-studied conditions on ClinicalTrials.gov are Healthy, Type 2 Diabetes Mellitus, Chronic Hepatitis B, ST-segment Elevation Myocardial Infarction, Hyperlipidemia.